ISHARES TR's ticker is IBB and the CUSIP is 464287556. A total of 824 filers reported holding ISHARES TR in Q3 2022. The put-call ratio across all filers is 2.52 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $857,783 | +1.8% | 6,756 | +4.1% | 0.04% | -2.2% |
| Q1 2023 | $842,581 | -81.5% | 6,493 | -81.2% | 0.04% | -83.7% |
| Q4 2022 | $4,543,600 | +45.7% | 34,607 | +29.8% | 0.28% | +27.8% |
| Q3 2022 | $3,119,000 | +25891.7% | 26,669 | +25059.4% | 0.22% | +21500.0% |
| Q2 2022 | $12,000 | +500.0% | 106 | +960.0% | 0.00% | – |
| Q3 2021 | $2,000 | 0.0% | 10 | 0.0% | 0.00% | – |
| Q2 2021 | $2,000 | 0.0% | 10 | 0.0% | 0.00% | – |
| Q1 2021 | $2,000 | 0.0% | 10 | 0.0% | 0.00% | – |
| Q4 2020 | $2,000 | +100.0% | 10 | 0.0% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 10 | 0.0% | 0.00% | – |
| Q2 2020 | $1,000 | -66.7% | 10 | -60.0% | 0.00% | – |
| Q1 2020 | $3,000 | -25.0% | 25 | -28.6% | 0.00% | -100.0% |
| Q4 2019 | $4,000 | +33.3% | 35 | 0.0% | 0.00% | – |
| Q3 2019 | $3,000 | -57.1% | 35 | -44.4% | 0.00% | -100.0% |
| Q2 2019 | $7,000 | -99.4% | 63 | -99.4% | 0.00% | -99.5% |
| Q1 2019 | $1,247,000 | +69.4% | 11,154 | +84.9% | 0.22% | -9.5% |
| Q3 2018 | $736,000 | – | 6,032 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atom Investors LP | 78,501 | $10,139,189 | 5.52% |
| Bronte Capital Management Pty Ltd. | 302,076 | $39,016,136 | 4.53% |
| Michelson Medical Research Foundation, Inc. | 43,395 | $5,604,898 | 4.40% |
| Hackensack Meridian Health, Inc. | 228,000 | $29,448,480 | 4.26% |
| DAFNA Capital Management LLC | 102,500 | $13,238,900 | 3.97% |
| Richmond Brothers, Inc. | 16,724 | $2,159,856 | 3.64% |
| Alpha Family Trust | 34,549 | $4,462,349 | 3.53% |
| HANSEATIC MANAGEMENT SERVICES INC | 11,897 | $1,537 | 3.46% |
| PURSUE WEALTH PARTNERS LLC | 37,789 | $4,880,827 | 3.33% |
| Rye Brook Capital LLC | 40,100 | $5,179 | 3.17% |